PlainRecalls

Amneal Pharmaceuticals, Inc.

10 recalls on record · Latest: Dec 18, 2019

Subscribe to new Amneal Pharmaceuticals, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Amneal Pharmaceuticals, Inc. LIGHT-BOOK · SINGLE-AGENCY

#1,422 of 14,151 · 10 notices · 0.010% archive

  • BOOK 10 notices
  • RANK #1,422 of 14,151
  • SHARE 0.010% archive
  • AGENCY FDA Drug (10)
  • CAT drugs
  • CATS 1 category
  • LATEST Dec 18, 2019
  • PHOTO 4 Earth Farms formerl…

Nearest notice-volume peer: 4 Earth Farms formerly Mcl Fresh Inc (0 notice gap)

Amneal Pharmaceuticals, Inc. accounts for about 0.010% of the 104,423-notice archive on 10 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Amneal Pharmaceuticals, Inc.'s standing among 14,151 recalling firms

Amneal Pharmaceuticals, Inc. ranks 1,422nd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Amneal Pharmaceuticals, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

10 1422nd of 14151 higher than 12,602 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Amneal Pharmaceuticals, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Amneal Pharmaceuticals, Inc. holds about 0.010% of archive notices alongside 10 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Dec 18, 2019

Ranitidine Tablets, USP 300 mg - a).30-count bottles (NDC 65162-254-30), b).100-count bottles (NDC 65162-254-10) and c). 250-count bottles (NDC 65162-254-25).

FDA Drug Moderate Dec 18, 2019

Ranitidine Tablets, USP 300 mg, 250-count bottles, NDC 53746-254-02.

FDA Drug Moderate Dec 18, 2019

Ranitidine Tablets, USP 150 mg a).60-count bottles (NDC 65162-253-06) , b).100-count bottles (NDC 65162-253-10), c).180-count bottles (NDC 65162-253-18), d).500-count bottles (NDC 65162-253-50) and e)1000-count bottles (NDC 65162-253-11).

FDA Drug Moderate Dec 18, 2019

Ranitidine Tablets, USP 150 mg, 1000-count bottles, NDC 53746-253-10.

FDA Drug Moderate Dec 18, 2019

Ranitidine Syrup Oral Solution 15 mg/mL 6. fl. oz. (473 mL), NDC 65162-664-90.

FDA Drug Low Nov 20, 2019

Isotretinoin Capsules, USP 10 mg. Rx Only, 3 Prescription Blister Packs of 10- Capsules Each (30 Capsules)-. Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC 69238-1174-3

FDA Drug Low Oct 16, 2019

Benazepril HCl Tablets, USP 40 mg, 100 count bottles, Rx only, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ NDC 65162-754-10

FDA Drug Low Jul 31, 2019

Methylergonovine Maleate USP 0.2 mg Tablets a) 12 count (NDC 69238-1605-02) and b) 28 count bottles (NDC 69238-1605-08)

FDA Drug Low Jul 10, 2019

Esterified Estrogens & Methyltestosterone Tablets, USP 1.25 mg/2.5 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-172-01

FDA Drug Low Jul 10, 2019

Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-171-01

Amneal Pharmaceuticals, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Amneal Pharmaceuticals, Inc.?
PlainRecalls indexes 10 distinct federal recall events naming Amneal Pharmaceuticals, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Amneal Pharmaceuticals, Inc. sit among other recalling firms?
Amneal Pharmaceuticals, Inc. ranks #1,422 of 14,151 by distinct recall-event count among 14,151 firms in this archive (89th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Amneal Pharmaceuticals, Inc.'s notices?
FDA Drug accounts for 10 of this firm's 10 indexed notices.
What product category dominates Amneal Pharmaceuticals, Inc.'s filing book?
Filings for Amneal Pharmaceuticals, Inc. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous?
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Amneal Pharmaceuticals, Inc.: 10 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Amneal Pharmaceuticals, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026